CD BioGlyco offers αGal epitope synthesis-based cell-free system construction services. This service enables the controlled study of αGal epitopes and their interactions using purified αGal epitopes or synthetic αGal-containing molecules. It facilitates research into the functions and roles of αGal epitopes, particularly in fields like xenotransplantation and other biological processes.

The Custom αGal Epitope Synthesis-based Cell-free System Construction at CD BioGlyco

The αGal epitope is a carbohydrate structure that consists of a galactose molecule linked to a terminal galactose-alpha-1,3-galactose (αGal) structure. This epitope is not naturally expressed in humans but is present in many non-primate mammals, such as pigs and cows.

CD BioGlyco offers αGal epitope synthesis-based cell-free system construction service, enabling the study of αGal epitopes and their interactions in a controlled environment. This service facilitates experiments using purified αGal epitopes or synthetic αGal-containing molecules to examine their binding to antibodies or target proteins. Examples include enzyme-linked immunosorbent assay (ELISA) and glycan microarray techniques, allowing for precise investigation of αGal epitope interactions. Through this service, researchers gain insights into αGal epitope functions, relevant to areas like xenotransplantation and biological processes.

CD BioGlyco also provides various synthetic biology-based glycan production services. Utilizing our Cell Library, we tailor cell expression systems to match client requirements. We specialize in developing production chassis cells and offer Screening and Fermentation Engineering services. Moreover, our portfolio includes a selection of Pre-developed Glycan Products.

Fig.1 The process of construction of the cell-free αGal epitope system. (CD BioGlyco)

• Prepare the DNA template: If use a natural DNA template, extract it from the source organism. If use a synthetic DNA template, synthesize it using standard molecular biology techniques.
• Set up the cell-free protein synthesis system: This typically involves mixing the necessary components, such as ribosomes, amino acids, energy sources, and cofactors, in the appropriate buffer.
• Add the transcription and translation machinery: Mix the DNA template with the cell-free protein synthesis system. This will allow the transcription of the DNA template into mRNA and the subsequent translation of the mRNA into protein.
• Add the substrates: Add the necessary substrates for the synthesis of the αGal epitope, such as nucleotide sugars and glycosyltransferases, to the cell-free system. These substrates will be used by the enzymes encoded by the DNA template to synthesize the αGal epitope.
• Incubate the mixture: Incubate the mixture at the appropriate temperature and for the appropriate duration to allow transcription, translation, and enzymatic reactions to occur.
• Analyze the synthesized αGal epitope: After the incubation period, analyze the synthesized αGal epitope to confirm its presence and determine its quantity. This can be done using various techniques, such as immunoblotting or mass spectrometry.

Applications

• Researchers can use the cell-free system to investigate the binding interactions between αGal epitopes and antibodies. This aids in understanding immune responses and designing therapeutic antibodies.
• The system enables the screening of αGal epitope-containing molecules against a panel of proteins or antibodies. This helps in identifying potential drug candidates or understanding drug-protein interactions.
• By studying the αGal epitope, scientists can explore its role in xenotransplantation rejection and develop strategies to overcome immunological barriers in xenotransplantation.
• The αGal epitope synthesis-based cell-free system can be utilized in diagnostic assays, such as ELISA or glycan microarrays, for detecting αGal epitopes in biological samples.

Advantages

• Tailored to specific research needs, CD BioGlyco offers customized cell-free system construction services, allowing for flexibility in experimental design and optimization.
• CD BioGlyco prioritizes efficient project execution, offering rapid turnaround times for αGal epitope synthesis-based cell-free system construction, enabling timely research and development activities.
• CD BioGlyco fosters collaborative partnerships with clients, offering expert guidance and support throughout the project lifecycle, from initial planning to final delivery.

Similar Services at CD BioGlyco

CD BioGlyco is uniquely positioned to provide comprehensive and reliable αGal epitope synthesis-based cell-free system construction services, facilitating research and development efforts in glycobiology and related fields. Please feel free to contact us for more information, our team is dedicated to providing tailored solutions to meet your specific needs in glycobiology research and glycan production.

• N-linked 3'-Siallylactose-based Cell-free System Construction Service
• 6'-Siallylactose-based Cell-free System Construction Service
• Pyruvylated Lactose-based Cell-free System Construction Service
• 2'-Fucosyllactose-based Cell-free System Construction Service
• 3-Fucosyllactose-based Cell-free System Construction Service
• Mono- or Di- Fucosylated Lactose-based Cell-free System Construction Service
• Mono- or Di-Fucosylated LacNAc-based Cell-free System Construction Service
• Sialylated Lactose-based Cell-free System Construction Service
• Sialylated LacNAc-based Cell-free System Construction Service